Osman Faruk Öztürk – Trademark Portfolio

Entity Type: 01

Osman Faruk Öztürk holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 14 (Jewelry) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ETERNATE. The owner is based in KADIKÖY / İSTANBUL (TR).

FENERYOLU MAH. HAMDİBEY SK. ÇOLAKOĞLU,

APT NO: 12 İÇ KAPI NO: 24

KADIKÖY / İSTANBUL (TR) , TR

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ETERNATE
ETERNATE
Registered 2024

Trademark Classifications

Osman Faruk Öztürk's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

14
Jewelry (1 filing)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Osman Faruk Öztürk have?

Osman Faruk Öztürk has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Osman Faruk Öztürk file in?

Osman Faruk Öztürk files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 14 (Jewelry). Class 35 covers advertising; business management; business administration; office functions.

What are Osman Faruk Öztürk's most well-known trademarks?

Osman Faruk Öztürk's registered trademark portfolio includes well-known marks such as ETERNATE. These are among 1 currently registered trademark in the portfolio.

What is Osman Faruk Öztürk's trademark registration success rate?

Osman Faruk Öztürk has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.